Nature Biotechnology podcast: First Rounders with Julian Davies

Julian Davies

{credit}Image courtesy of Julian Davies{/credit}

Contributor Brady Huggett

Julian Davies has a long history in biotechnology research, particularly in antibiotics and resistance, and he also served as head of research at Biogen’s European division in the 1980s. But for more than 20 years now, he’s been at the University of British Columbia (UBC), where he’s the principal investigator at the Davies Lab. I spoke to Julian for the Nature Biotechnology First Rounders podcast, which was recorded in his office on the UBC campus, with the door closed to help with audio quality, and the overhead lights off. A light rain fell against his office window.

We talked at length about his early family life during World War II, his education in chemistry and biology, and his research across countries. A Nature Biotechnology profile in 2008 had covered TerraGen, Davies’ spinout from UBC, and it’s a topic in the podcast, too. But the element that perhaps stands out most is his eagerness to move around: he’s lived in New York, Manchester, Boston, Paris, Geneva, and beyond – partly to follow research he found interesting, and partly, it seems, because he was perpetually invited to work alongside others. This willingness to relocate helped facilitate his career, as well as allowed him to see the world.

Hear more about Julian’s life on the Nature Biotechnology First Rounders podcast.

Brady Huggett is the Business Editor for Nature Biotechnology

Coming Soon

First post on a new blog. It’s like walking across fresh snow.

This blog will officially launch March 8, 2011, in coordination with the 15-year anniversary of Nature Biotechnology. (It was founded as Bio/Technology in 1983 but renamed Nature Biotechnology in 1996.) In the meantime, some information: you can find the homepage for Nature Biotechnology here and our Bioentrepreneur portal here. You can follow Nature Biotechnology‘s Twitter feed by going here (we’re @naturebiotech).

In general, though, you won’t hear much from me on this blog. We’ve accrued a great group of contributors located around the globe (for our current roster, visit the About page; click on author names for bios) and mostly I’ll just pass along information or otherwise help moderate the conversation. I’d like to also extend special thanks to Justin Chakma, for co-founding this blog.

Thanks for your interest, and we’ll be live in March.

Brady Huggett

Business Editor, Nature Biotechnology